Newstral
Article
jdsupra.com on 2019-08-07 19:28
340B Update: CMS Addresses Ongoing Litigation and Reimbursement Changes for 340B Drugs in CY 2020 OPPS Proposed Rule
Related news
- 340B Update: D.C. District Court Overturns OPPS 340B Reimbursement Cut for CY 2018jdsupra.com
- 340B Update: CMS Maintains Payment Reductions for 340B Drugs in CY 2020 OPPS Final Rulejdsupra.com
- CMS Continues 340B Drug Reimbursement Reductions Despite Ongoing Litigationjdsupra.com
- CMS Issues CY 2019 OPPS Final Rulejdsupra.com
- CMS expands reimbursement cuts on 340B drugsjdsupra.com
- DC Circuit Upholds OPPS Reimbursement Reductions for 340B Drugsjdsupra.com
- CY 2020 OPPS Proposed Rule – HHS Seeks Comments on 340B Payment Reductions and Remediesjdsupra.com
- CMS Delays Price Transparency, Doubles Down on Site-Neutral and 340B Payment Policies in CY 2020 OPPS Final Rulejdsupra.com
- 340B Drug Pricing Program Litigation Update: Court Rejects CMS Drug Pricing Cutsjdsupra.com
- SCOTUS 340B Decision Drives CMS to Restore Part B 340B Payments and Seek Comments on Remedies in the CY 2023 OPPS Proposed Rulejdsupra.com
- CMS restores 340B drug acquisition reimbursementjdsupra.com
- CMS Proposes Reimbursement Reduction for 340B Drugsjdsupra.com
- CMS Finalizes 340b Payment Provisions in 2023 OPPS Final Rulejdsupra.com
- CMS Postpones OPPS “Exact Match” Address Requirements Until October 2019jdsupra.com
- 340B Update: Hospital Groups File (...and Refile) 340B Program Litigationjdsupra.com
- CMS Proposes Medicare OPPS, ASC Update for CY 2018jdsupra.com
- CMS Releases CY 2023 OPPS and ASC Proposed Rulejdsupra.com
- CMS Releases CY 2022 OPPS and ASC Proposed Rulejdsupra.com
- CMS Releases CY 2024 OPPS and ASC Final Rulejdsupra.com
- CY 2019 OPPS Proposed Rule Extends Site Neutral Policiesjdsupra.com